496 related articles for article (PubMed ID: 15862527)
1. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
2. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
3. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour.
Scott V; Kimura N; Stark JA; Luckman SM
J Neuroendocrinol; 2005 Jul; 17(7):452-7. PubMed ID: 15946163
[TBL] [Abstract][Full Text] [Related]
4. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
[TBL] [Abstract][Full Text] [Related]
5. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
6. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
Riediger T; Bothe C; Becskei C; Lutz TA
Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
[TBL] [Abstract][Full Text] [Related]
7. PYY(3-36) into the arcuate nucleus inhibits food deprivation-induced increases in food hoarding and intake.
Teubner BJ; Bartness TJ
Peptides; 2013 Sep; 47():20-8. PubMed ID: 23816798
[TBL] [Abstract][Full Text] [Related]
8. Gut hormone PYY(3-36) physiologically inhibits food intake.
Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR
Nature; 2002 Aug; 418(6898):650-4. PubMed ID: 12167864
[TBL] [Abstract][Full Text] [Related]
9. Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
Malmström RE
Br J Pharmacol; 2001 Aug; 133(7):1073-80. PubMed ID: 11487518
[TBL] [Abstract][Full Text] [Related]
10. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
12. The gut hormone peptide YY regulates appetite.
Batterham RL; Bloom SR
Ann N Y Acad Sci; 2003 Jun; 994():162-8. PubMed ID: 12851312
[TBL] [Abstract][Full Text] [Related]
13. Peptide YY induces characteristic meal patterns of aged mice.
Mogami S; Yamada C; Fujitsuka N; Hattori T
Horm Behav; 2017 Nov; 96():62-68. PubMed ID: 28916138
[TBL] [Abstract][Full Text] [Related]
14. NPY2 receptor activation in the dorsal vagal complex increases food intake and attenuates CCK-induced satiation in male rats.
Huston NJ; Brenner LA; Taylor ZC; Ritter RC
Am J Physiol Regul Integr Comp Physiol; 2019 Apr; 316(4):R406-R416. PubMed ID: 30726118
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Tebbe JJ; Mronga S; Schäfer MK; Rüter J; Kobelt P; Mönnikes H
Am J Physiol Gastrointest Liver Physiol; 2003 Dec; 285(6):G1075-83. PubMed ID: 12855401
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
17. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Rimondini R; Thorsell A; Heilig M
Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
[TBL] [Abstract][Full Text] [Related]
19. The role of PYY in feeding regulation.
Ueno H; Yamaguchi H; Mizuta M; Nakazato M
Regul Pept; 2008 Jan; 145(1-3):12-6. PubMed ID: 17920705
[TBL] [Abstract][Full Text] [Related]
20. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.
Wang L; Gourcerol G; Yuan PQ; Wu SV; Million M; Larauche M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G45-56. PubMed ID: 19892938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
